Logo Unión Europea

Development of new complementary therapies for the treatment of oncological diseases

R&D Projects ONCOGALFARMA

GalChimia, Oncostellae, and AMSLab participates in the research project Oncogalfarma, whose goal is to develop new complementary therapies for the treatment of oncological diseases. The research is centered in the fields of inhibitors of protein–protein interactions (PPI) and nuclear receptors. The project has been financed by the Government of Galicia and co-financed by the European Regional Development Fund through the subprogramme CONECTA PEME. The total funding granted is €189,943.59. Click here for more information

Logo Xunta de Galicia
gain
Logo Galchimia letters

Subscribe to stay updated on the latest advances in organic synthesis and GalChimia’s good chemistry

     "*" mandatory

    I agree, and accept the data protection policy